News

In a sweeping regulatory move, the U.S. Food and Drug Administration (FDA) announced new safety labeling requirements for all ...
The U.S. Food and Drug Administration (FDA) has elevated the risk classification of a butter recall to the second-highest ...
Two of the leading developers of Car-T immuno-oncology drugs, Imugene and Chimeric have unveiled further positive trial ...